Reproducibility of reference tissue quantification of dynamic contrast-enhanced data: Comparison with a fixed vascular input function

Physics in Medicine and Biology

Volumn 52, Issue 1, 2007, Pages 75-89

  Walker Samuel, S ^a   Parker, C C ^a   Leach, M O ^a   Collins, D J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; ONCOLOGY; PLASMAS;

ANTI-CANCER DRUGS; CONTRAST ENHANCED DATA; PLASMA KINETICS;

TISSUE;

ARTICLE; CONTRAST ENHANCEMENT; HEMODYNAMICS; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SKELETAL MUSCLE; STANDARD; STATISTICAL PARAMETERS; VALIDATION PROCESS; VASCULARIZATION; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HUMAN; IMAGE PROCESSING; KINETICS; MALE; MONTE CARLO METHOD; MUSCLE; PATHOLOGY; STATISTICAL MODEL; TIME;

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; PROTON;

ANTINEOPLASTIC AGENTS; COHORT STUDIES; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KINETICS; MAGNETIC RESONANCE IMAGING; MALE; MODELS, STATISTICAL; MONTE CARLO METHOD; MUSCLES; PROTONS; REFERENCE STANDARDS; TIME FACTORS;

EID: 34247525236     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/52/1/006     Document Type: Article

References (25)

1. Bland J M and Altman D G 1986 Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 307-10
2. Bland J M and Altman D G 1999 Measuring agreement in method comparison studies Stat. Methods Med. Res. 8 135-60
3. Cron G O, Kelcz F and Santyr G E 2004 Improvement in breast lesion characterization with dynamic contrast-enhanced MRI using pharmacokinetic modeling and bookend T(1) measurements Magn. Reson. Med. 51 1066-70
4. d'Arcy J A, Collins D J, Rowland I J, Padhani A R and Leach M O 2002 Applications of sliding window reconstruction with Cartesian sampling for dynamic contrast enhanced MRI NMR Biomed. 15 174-83
5. Donahue K M, Weisskoff R M, Parmelee D J, Callahan R J, Wilkinson R A, Mandeville J B and Rosen B R 1995 Dynamic Gd-DTPA enhanced MRI measurement of tissue cell volume fraction Magn. Reson. Med. 34 423-32
6. Gee M S, Procopio W N, Makonnen S, Feldman M D, Yeilding N M and Lee W M 2003 Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy Am. J. Pathol. 162 183-93
7. Haake E, Brown R, Thompson M and Venkatesan R 1999 Magnetic Resonance Imaging: Physical Principles and Sequence Design (Chichester: Wiley-Liss)
8. Hittmair K, Gomiscek G, Langenberger K, Recht M, Imhof H and Kramer J 1994 Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI Magn. Reson. Med. 31 567-71
9. Kety S S 1951 The theory and applications of the exchange of inert gas at the lungs and tissues Pharmacol. Rev. 3 1-41
10. Kovar D A, Lewis M and Karczmar G S 1998 A new method for imaging perfusion and contrast extraction fraction: input functions derived from reference tissues J. Magn. Reson. Imaging 8 1126-34
11. Leach M O et al 2005 The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations Br. J. Cancer 92 1599-610
12. Levett D 2003 The pharmacokinetics of the interstital space in humans BMC Pharmacol. 3 3
13. Lutz A M, Weishaupt D, Amann-Vesti B R, Pfammatter T, Goepfert K, Marincek B and Nanz D 2004 Assessment of skeletal muscle perfusion by contrast medium first-pass magnetic resonance imaging: technical feasibility and preliminary experience in healthy volunteers J. Magn. Reson. Imaging 20 111-21
14. Padhani A R 2002 Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions J. Magn. Reson. Imaging 16 407-22
15. Padhani A R, Hayes C, Landau S and Leach M O 2002 Reproducibility of quantitative dynamic MRI of normal human tissues NMR Biomed. 15 143-53
16. Port R E, Knopp M V and Brix G 2001 Dynamic contrast-enhanced MRI using Gd-DTPA: interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors Magn. Reson. Med. 45 1030-8
17. Press W H, Teukolsky S A, Vettering W T and Flannery B P 1988 Numerical Recipes in C 2nd edn (Cambridge: Cambridge University Press)
18. Rijpkema M, Kaanders J H, Joosten F B, van der Kogel A J and Heerschap A 2001 Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors J. Magn. Reson. Imaging 14 457-63
19. Tofts P S et al 1999 Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols J. Magn. Reson. Imaging 10 223-32
20. Tofts P S and Kermode A G 1991 Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging: 1. Fundamental concepts Magn. Reson. Med. 17 357-67
21. Walker-Samuel S, Knowles B R, d'Arcy J A, Smith N J, Parker C, Brown G, Leach M O and Collins D J 2006 Blood plasma Gd-DTPA concentration derived from skeletal muscle is comparable with a direct measurement from the aorta Int. Soc. Magnetic Resonance Imaging in Medicine (Seattle)
22. Walker-Samuel S, Leach M O and Collins D J 2006 Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis Phys. Med. Biol. 51 3593-602
23. Weinmann H J, Laniado M and Mutzel W 1984 Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers Physiol. Chem. Phys. Med. NMR 16 167-72
24. Yang C, Karczmar G S, Medved M and Stadler W M 2004 Estimating the arterial input function using two reference tissues in dynamic contrast-enhanced MRI studies: fundamental concepts and simulations Magn. Reson. Med. 52 1110-7
25. Yankeelov T E, Luci J J, Lepage M, Li R, Debusk L, Lin P C, Price R R and Gore J C 2005 Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model Magn. Reson. Imaging 23 519-29